CACNB3 Gene Record

  • VERAPAMIL   CACNB3

    Interaction Score: 0.61

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name Verapamil,Calan, Covera-HS
    Novel drug target Established target

    PMIDs:
    19125880


    Sources:
    TdgClinicalTrial TEND

  • SAFINAMIDE   CACNB3

    Interaction Score: 0.46

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Safinamide
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • BEPRIDIL HYDROCHLORIDE   CACNB3

    Interaction Score: 0.27

    Interaction Types & Directionality:
    blocker (inhibitory)

    Interaction Info:
    Mechanism of Interaction Voltage-gated calcium channel blocker
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • GABAPENTIN ENACARBIL   CACNB3

    Interaction Score: 0.27

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Mechanism of Interaction Voltage-gated calcium channel modulator
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • IMAGABALIN   CACNB3

    Interaction Score: 0.27

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Mechanism of Interaction Voltage-gated calcium channel modulator
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • PREGABALIN   CACNB3

    Interaction Score: 0.27

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Mechanism of Interaction Voltage-gated calcium channel modulator
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • ATAGABALIN   CACNB3

    Interaction Score: 0.27

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Mechanism of Interaction Voltage-gated calcium channel modulator
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • GABAPENTIN   CACNB3

    Interaction Score: 0.25

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Mechanism of Interaction Voltage-gated calcium channel modulator
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • CELECOXIB   CACNB3

    Interaction Score: 0.22

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22336956


    Sources:
    PharmGKB

  • Ensembl: ENSG00000167535

    • Version: 101_38

    Alternate Names:
    CACNB3 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • TEND: P54284

    • Version: 01-August-2011

    Alternate Names:
    P54284 Uniprot Accession
    CACB3_HUMAN Uniprot Id
    ENSG00000167535 Ensembl Gene Id

    Gene Info:
    Target Main Class Transporters
    Target Subclass AuxillaryTransportUnit

    Publications:

  • TdgClinicalTrial: P54284

    • Version: January-2014

    Alternate Names:
    CACNB3 Gene Symbol

    Gene Info:
    Target Class Transporters
    Target Subclass TC:8.A.22.1.3

    Publications:

  • PharmGKB: CACNB3

    • Version: 18-August-2020

    Alternate Names:
    PA89 PharmGKB ID

    Gene Info:

    Publications:
    Gong L et al., 2012, Celecoxib pathways: pharmacokinetics and pharmacodynamics., Pharmacogenet Genomics

  • ChemblInteractions: CACNLB3

    • Version: chembl_23

    Alternate Names:
    CACNLB3 GENE_SYMBOL
    CACNB3 GENE_SYMBOL
    Voltage-dependent L-type calcium channel subunit beta-3 UNIPROT

    Gene Info:

    Publications:

  • HingoraniCasas: ENSG00000167535

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000167535 Gene Symbol
    CACNB3 Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • Pharos: CACNB3

    • Version: 01-February-2022

    Alternate Names:
    Voltage-dependent L-type calcium channel subunit beta-3 Gene Name
    P54284 UniProt ID

    Gene Info:

    Gene Categories:
    ION CHANNEL, TRANSCRIPTION FACTOR

    Publications: